Ana Paula Pereira Velosa Selected Research

Lung Neoplasms (Lung Cancer)

2/2010

Refractory remodeling of the microenvironment by abnormal type V collagen, apoptosis, and immune response in non-small cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ana Paula Pereira Velosa Research Topics

Disease

7	Fibrosis (Cirrhosis) 01/2021 - 07/2006
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 02/2010
4	Neoplasms (Cancer) 01/2022 - 08/2016
4	Systemic Scleroderma (Systemic Sclerosis) 01/2020 - 07/2006
3	Inflammation (Inflammations) 09/2020 - 01/2016
3	Idiopathic Pulmonary Fibrosis 01/2020 - 12/2006
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 09/2020 - 10/2018
2	Arthritis (Polyarthritis) 01/2018 - 11/2007
2	Atrophy 07/2007 - 07/2006
1	Atherosclerosis 10/2022
1	Dyslipidemias (Dyslipidemia) 10/2022
1	Insulin Resistance 10/2022
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Carcinoma (Carcinomatosis) 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Primitive Neuroectodermal Tumors (PNET) 01/2021
1	Lung Diseases (Lung Disease) 09/2020
1	Granuloma 09/2020
1	Silicosis 09/2020
1	Tibial Fractures (Fracture, Tibial) 01/2020
1	Interstitial Lung Diseases (Interstitial Lung Disease) 12/2019
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2019
1	Necrosis 09/2018
1	Tendinopathy (Tendonitis) 09/2018
1	Experimental Arthritis 01/2018
1	Edema (Dropsy) 01/2018
1	Synovitis 01/2018
1	Body Weight (Weight, Body) 08/2016
1	Adenocarcinoma 08/2016
1	Carcinogenesis 08/2016
1	Liver Cirrhosis (Hepatic Cirrhosis) 03/2016
1	Biliary Atresia 03/2016
1	Pneumonia (Pneumonitis) 01/2016
1	Lung Neoplasms (Lung Cancer) 02/2010
1	Pain (Aches) 11/2007
1	Vasculitis (Vasculitides) 07/2006

Drug/Important Bio-Agent (IBA)

14	CollagenIBA 01/2022 - 07/2006
8	Collagen Type V (Type V Collagen)IBA 01/2020 - 07/2006
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2016
3	Bleomycin (Blenoxane)FDA LinkGeneric 09/2020 - 01/2016
2	alpha2 Subunit Collagen Type IIBA 01/2021 - 12/2019
2	CytokinesIBA 01/2019 - 01/2016
2	Collagen Type I (Type I Collagen)IBA 01/2018 - 03/2016
2	Freund's AdjuvantIBA 01/2018 - 07/2006
2	Caspase 9IBA 01/2018 - 08/2016
1	Lipoproteins (Lipoprotein)IBA 10/2022
1	beta-Aminoethyl Isothiourea (AET)IBA 10/2022
1	Triglycerides (Triacylglycerol)IBA 10/2022
1	CholesterolIBA 10/2022
1	SodiumIBA 10/2022
1	LDL Receptors (LDL Receptor)IBA 10/2022
1	LipidsIBA 10/2022
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2022
1	ElastinIBA 01/2022
1	Hyaluronic Acid (Hyaluronan)IBA 01/2022
1	Hematoxylin (Haematoxylon)IBA 01/2022
1	IntegrinsIBA 01/2021
1	Collagen Type III (Type III Collagen)IBA 01/2021
1	Silicon Dioxide (Silica)FDA LinkGeneric 09/2020
1	PPAR gammaIBA 09/2020
1	SmokeIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Peptides (Polypeptides)IBA 01/2020
1	AutoantigensIBA 12/2019
1	Corn Oil (Oil, Corn)IBA 10/2018
1	Butylated Hydroxytoluene (BHT)IBA 10/2018
1	Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA 09/2018
1	methylated bovine serum albumin (MBSA)IBA 01/2018
1	Urethane (Ethyl Carbamate)IBA 08/2016

Therapy/Procedure

3	Therapeutics 01/2022 - 11/2007
1	Sodium-Restricted Diet (Diet, Sodium Restricted) 10/2022
1	Immunotherapy 01/2021
1	Oral Administration 01/2018
1	Intranasal Administration 08/2016
1	Hepatic Portoenterostomy 03/2016
1	Mud Therapy (Mud Bath) 11/2007